Skip to main content

Published locations for Benralizumab Now FDA Approved to Treat EGPA Vasculitis

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Benralizumab Now FDA Approved to Treat EGPA Vasculitis

User login

  • Reset your password
  • /content/benralizumab-now-fda-approved-treat-egpa-vasculitis
  • /familypracticenews/article/270877/lupus-connective-tissue-diseases/benralizumab-now-fda-approved
  • /internalmedicinenews/article/270877/lupus-connective-tissue-diseases/benralizumab-now-fda-approved
  • /rheumatologynews/article/270877/lupus-connective-tissue-diseases/benralizumab-now-fda-approved-treat
  • /rheumatology/article/270877/lupus-connective-tissue-diseases/benralizumab-now-fda-approved-treat
  • /internalmedicine/article/270877/lupus-connective-tissue-diseases/benralizumab-now-fda-approved-treat
  • /familymedicine/article/270877/lupus-connective-tissue-diseases/benralizumab-now-fda-approved-treat
  • /chestphysician/article/270877/lupus-connective-tissue-diseases/benralizumab-now-fda-approved-treat